Results 281 to 290 of about 62,999,708 (406)
Pharmaceutical Analysis by Polarography. V
Kazuo Matsumoto, T. Matsui
openalex +2 more sources
Classification of acute myeloid leukemia based on multi‐omics and prognosis prediction value
The Unsupervised AML Multi‐Omics Classification System (UAMOCS) integrates genomic, methylation, and transcriptomic data to categorize AML patients into three subtypes (UAMOCS1‐3). This classification reveals clinical relevance, highlighting immune and chromosomal characteristics, prognosis, and therapeutic vulnerabilities.
Yang Song+13 more
wiley +1 more source
Monocyte CCL2 signaling possibly contributes to increased asthma susceptibility in type 2 diabetes. [PDF]
Luo T, Guo W, Ji W, Du W, Lv Y, Feng Z.
europepmc +1 more source
Application of factor analysis to the yield of rice-crop experiments. (2)
M. NAKAHARA, M. MITSUTERA
openalex +2 more sources
Adverse prognosis gene expression patterns in metastatic castration‐resistant prostate cancer
We aggregated a cohort of 1012 mCRPC tissue samples from 769 patients and investigated the association of gene expression‐based pathways with clinical outcomes. Loss of AR signaling, high proliferation, and a glycolytic phenotype were independently prognostic for poor outcomes, and an adverse transcriptional feature score incorporating these pathways ...
Marina N. Sharifi+26 more
wiley +1 more source
GWAS meta-analysis using a graph-based pan-genome enhanced gene mining efficiency for agronomic traits in rice. [PDF]
Yang L+33 more
europepmc +1 more source
Analysis on the Cut Depth in Travelling Nozzle-Blasting with Steel Grit
Shokichi HIROSE
openalex +2 more sources
TOMM20 increases cancer aggressiveness by maintaining a reduced state with increased NADH and NADPH levels, oxidative phosphorylation (OXPHOS), and apoptosis resistance while reducing reactive oxygen species (ROS) levels. Conversely, CRISPR‐Cas9 knockdown of TOMM20 alters these cancer‐aggressive traits.
Ranakul Islam+9 more
wiley +1 more source
Integrating single-cell RNA sequencing, WGCNA, and machine learning to identify key biomarkers in hepatocellular carcinoma. [PDF]
Wang G+10 more
europepmc +1 more source